Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer

[1]  E. Oki,et al.  Impact of a metastatic site on circulating tumor DNA (ctDNA) analysis in patients (pts) with metastatic colorectal cancer (mCRC). , 2021 .

[2]  A. Cervantes,et al.  Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review , 2021, Cancers.

[3]  R. Yamashita,et al.  Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies , 2020, Nature Medicine.

[4]  Song Wu,et al.  Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade. , 2020, Cancer discovery.

[5]  T. Rikiyama,et al.  Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer , 2019, PloS one.

[6]  R. Kurzrock,et al.  Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer , 2019, Journal of Hematology & Oncology.

[7]  J. Ross,et al.  Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. , 2019, Gastroenterology.

[8]  M. Tempero.  NCCN Guidelines Updates: Pancreatic Cancer. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[9]  Akihiko Yoshida,et al.  Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study , 2019, Cancer science.

[10]  C. Paweletz,et al.  Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies , 2018, Clinical Cancer Research.

[11]  Levi Garraway,et al.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.

[12]  Donavan T. Cheng,et al.  Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.

[13]  S. Horiguchi,et al.  Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[14]  Katherine Van Loon,et al.  Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas. , 2015, Cancer discovery.

[15]  C. Galbán,et al.  Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. , 2012, The Journal of clinical investigation.